Daratumumab Now First-Line in Myeloma in US Daratumumab Now First-Line in Myeloma in US

Daratumumab becomes the first antibody approved for first-line use in the treatment of newly diagnosed multiple myeloma, in combination with three other agents.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news